David Barr
Family Medicine · New Castle, INNPI 1437239969
Payments from drug & device makers
Across 77 payments — averaging $15.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$213
- Astellas Pharma US Inc$139
- AbbVie$124
- Lilly USA, LLC$102
- GSK$78
- Boehringer Ingelheim$73
- plus $491 from 20 others
What the payments were for
- Food & beverage$1,220100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 14 | $213 |
| Astellas Pharma US Inc | 8 | $139 |
| AbbVie(2 entities) | 8 | $124 |
| Lilly USA, LLC | 6 | $102 |
| GSK | 5 | $78 |
| Boehringer Ingelheim | 5 | $73 |
| Pfizer | 4 | $66 |
| Medtronic | 3 | $45 |
| Jazz Pharmaceuticals Inc. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| Johnson & Johnson | 2 | $27 |
| Amgen | 2 | $25 |
| Abbott | 1 | $19 |
| Bayer | 1 | $18 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Exact Sciences | 1 | $15 |
| Biogen | 1 | $15 |
| Boston Scientific | 1 | $14 |
| Novartis | 1 | $13 |
| Merck | 1 | $13 |
| Echosens North America, Inc. | 1 | $13 |
| AstraZeneca | 1 | $13 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
How this compares
$1,220 in reported general payments places this provider in the 60th percentile of 2,709 family medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TradjentaLinagliptin | 48 | $49,519 |
| EliquisApixaban | 42 | $32,298 |
| MounjaroTirzepatide | 20 | $27,195 |
| JanuviaSitagliptin Phosphate | 16 | $25,804 |
| TrulicityDulaglutide | 16 | $24,233 |
| Breo ElliptaFluticasone/Vilanterol | 41 | $20,084 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $11,554 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 89 | $11,114 |
| FarxigaDapagliflozin Propanediol | 11 | $9,097 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $7,527 |
| DuleraMometasone/Formoterol | 20 | $7,081 |
| Atorvastatin Calcium | 484 | $3,843 |
| JanumetSitagliptin Phos/Metformin Hcl | 12 | $3,527 |
| Omeprazole | 200 | $3,058 |
| Levothyroxine Sodium | 275 | $2,323 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $102 | $51,42836 claims |
| Boehringer IngelheimTradjenta | $73 | $49,51948 claims |
| MerckJanuvia, Dulera, Janumet | $13 | $36,41248 claims |
| PfizerEliquis | $66 | $32,29842 claims |
| GSKBreo Ellipta, Trelegy Ellipta | $78 | $31,63859 claims |
| AstraZenecaFarxiga | $13 | $9,09711 claims |
| AbbVieSynthroid | $124 | $2,28532 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,709 family medicine providers in Indiana.
Other family medicine in New Castle
- Blair BrengleIndianapolis$10.6M
- Laura HelmanMishawaka$4M
- J Christopher SartoreEvansville$3.9M
- Hubert ReyesEvansville$3.2M
- David SchultzEvansville$3M
- Steven SmithIndianapolis$2.5M
- Renee Michelle GalenNewburgh$2.1M
- Eric HewittAvon$1.7M
- Alexander Dela LlanaEvansville$1.6M
- Jonathan ConditMuncie$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.